Literature DB >> 16855129

Preference-Based EQ-5D index scores for chronic conditions in the United States.

Patrick W Sullivan1, Vahram Ghushchyan.   

Abstract

BACKGROUND: The Panel on Cost-Effectiveness in Health and Medicine has called for an "off-the-shelf" catalogue of nationally representative, community-based preference scores for health states, illnesses, and conditions. A previous review of cost-effectiveness analyses found that 77% did not incorporate community-based preferences, and 33% used arbitrary expert or author judgment. These results highlight the necessity of making a wide array of appropriate, community-based estimates more accessible to cost-effectiveness researchers.
OBJECTIVE: To provide nationally representative EQ-5D index scores for chronic ICD-9 codes.
METHODS: The nationally representative Medical Expenditure Panel Survey (MEPS) was pooled (2000-2002) to create a data set of 38,678 adults. Ordinary least squares (OLS), Tobit, and censored least absolute deviations (CLAD) regression methods were used to estimate the marginal disutility of each condition, controlling for age, comorbidity, gender, race, ethnicity, income, and education.
RESULTS: Most chronic conditions, age, comorbidity, income, and education were highly statistically significant predictors of EQ-5D index scores. Homoskedasticity and normality assumptions were rejected, suggesting only CLAD estimates are theoretically unbiased. The magnitude and statistical significance of coefficients varied by analytic method. OLS and Tobit coefficients were on average 60% and 143% greater than CLAD, respectively. The marginal disutility of 95 chronic ICD-9 codes as well as unadjusted mean, median, and 25th and 75th percentiles are reported.
CONCLUSION: This research provides nationally representative, community-based EQ-5D index scores associated with a wide variety of chronic ICD-9 codes that can be used to estimate quality-adjusted life-years in cost-effectiveness analyses.

Mesh:

Year:  2006        PMID: 16855129      PMCID: PMC2634296          DOI: 10.1177/0272989X06290495

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  19 in total

1.  Out-of-pocket medical spending for care of chronic conditions.

Authors:  W Hwang; W Weller; H Ireys; G Anderson
Journal:  Health Aff (Millwood)       Date:  2001 Nov-Dec       Impact factor: 6.301

Review 2.  An off-the-shelf help list: a comprehensive catalog of preference scores from published cost-utility analyses.

Authors:  C M Bell; R H Chapman; P W Stone; E A Sandberg; P J Neumann
Journal:  Med Decis Making       Date:  2001 Jul-Aug       Impact factor: 2.583

Review 3.  Bayesian extensions of the Tobit model for analyzing measures of health status.

Authors:  Peter C Austin
Journal:  Med Decis Making       Date:  2002 Mar-Apr       Impact factor: 2.583

Review 4.  Measurement of health state utilities for economic appraisal.

Authors:  G W Torrance
Journal:  J Health Econ       Date:  1986-03       Impact factor: 3.883

5.  Multiattribute and single-attribute utility functions for the health utilities index mark 3 system.

Authors:  David Feeny; William Furlong; George W Torrance; Charles H Goldsmith; Zenglong Zhu; Sonja DePauw; Margaret Denton; Michael Boyle
Journal:  Med Care       Date:  2002-02       Impact factor: 2.983

6.  Mexican-American, black-American and white-American differences in reporting illnesses, disability and physician visits for illnesses.

Authors:  E Berkanovic; C Telesky
Journal:  Soc Sci Med       Date:  1985       Impact factor: 4.634

7.  The measurement of patients' values in medicine.

Authors:  H Llewellyn-Thomas; H J Sutherland; R Tibshirani; A Ciampi; J E Till; N F Boyd
Journal:  Med Decis Making       Date:  1982       Impact factor: 2.583

8.  Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial.

Authors:  A W Wu; K L Jacobson; K D Frick; R Clark; D A Revicki; K A Freedberg; J Scott-Lennox; J Feinberg
Journal:  Qual Life Res       Date:  2002-05       Impact factor: 4.147

9.  Measuring population health: a comparison of three generic health status measures.

Authors:  Susan Macran; Helen Weatherly; Paul Kind
Journal:  Med Care       Date:  2003-02       Impact factor: 2.983

10.  A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease.

Authors:  Nan Luo; Ling-Huo Chew; Kok-Yong Fong; Dow-Rhoon Koh; Swee-Cheng Ng; Kam-Hon Yoon; Sheila Vasoo; Shu-Chuen Li; Julian Thumboo
Journal:  J Rheumatol       Date:  2003-10       Impact factor: 4.666

View more
  225 in total

1.  Approach to asymptomatic paraesophageal hernia: watchful waiting or elective laparoscopic hernia repair?

Authors:  James J Jung; David M Naimark; Ramy Behman; Teodor P Grantcharov
Journal:  Surg Endosc       Date:  2017-08-04       Impact factor: 4.584

2.  The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer.

Authors:  T Younis; D Rayson; C Skedgel
Journal:  Curr Oncol       Date:  2011-12       Impact factor: 3.677

3.  The impact of using different tariffs to value EQ-5D health state descriptions: an example from a study of acute cough/lower respiratory tract infections in seven countries.

Authors:  Raymond Oppong; Billingsley Kaambwa; Jacqueline Nuttall; Kerenza Hood; Richard D Smith; Joanna Coast
Journal:  Eur J Health Econ       Date:  2011-11-05

4.  The impact of co-morbidity burden on preference-based health-related quality of life in the United States.

Authors:  Patrick W Sullivan; Vahram H Ghushchyan; Elizabeth A Bayliss
Journal:  Pharmacoeconomics       Date:  2012-05       Impact factor: 4.981

5.  The English and Chinese versions of the five-level EuroQoL Group's five-dimension questionnaire (EQ-5D) were valid and reliable and provided comparable scores in Asian breast cancer patients.

Authors:  Chun Fan Lee; Raymond Ng; Nan Luo; Nan Soon Wong; Yoon Sim Yap; Soo Kien Lo; Whay Kuang Chia; Alethea Yee; Lalit Krishna; Celest Wong; Cynthia Goh; Yin Bun Cheung
Journal:  Support Care Cancer       Date:  2012-06-06       Impact factor: 3.603

6.  Preference-based health-related quality of life among victims of bullying.

Authors:  Linda Beckman; Mikael Svensson; Ann Frisén
Journal:  Qual Life Res       Date:  2015-08-14       Impact factor: 4.147

7.  Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 Diabetes in Canada.

Authors:  R Brett McQueen; Marc D Breton; Markus Ott; Helena Koa; Bruce Beamer; Jonathan D Campbell
Journal:  J Diabetes Sci Technol       Date:  2015-08-14

8.  Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?

Authors:  E Losina; M E Daigle; L G Suter; D J Hunter; D H Solomon; R P Walensky; J M Jordan; S A Burbine; A D Paltiel; J N Katz
Journal:  Osteoarthritis Cartilage       Date:  2013-02-04       Impact factor: 6.576

9.  Health-related quality of life associated with systemic corticosteroids.

Authors:  Patrick W Sullivan; Vahram H Ghushchyan; Gary Globe; Brandon Sucher
Journal:  Qual Life Res       Date:  2016-10-18       Impact factor: 4.147

10.  US valuation of health outcomes measured using the PROMIS-29.

Authors:  Benjamin M Craig; Bryce B Reeve; Paul M Brown; David Cella; Ron D Hays; Joseph Lipscomb; A Simon Pickard; Dennis A Revicki
Journal:  Value Health       Date:  2014-12       Impact factor: 5.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.